GlassScriptPhysician profile
Cheyenne Roohani
NPI 1114422342
$2,745.18
in general payments reported to CMS, 2019-2025
8 companies · $737 in 2025
The $737 reported for 2025 was more than what 82% of Pediatric Otolaryngology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,587 · 2022: $354 · 2024: $67.34 · 2025: $737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $468 · Food and Beverage: $336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $468.03 |
| Food and Beverage | $336.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,239.32 | 2021-2022 | |
| Inspire Medical Systems, INC. | $708.41 | 2025 | Inspire |
| Depuy Synthes Sales INC. | $301.40 | 2021-2022 | |
| Medical Device Business Services, INC. | $279.98 | 2021 | |
| Karl Storz Endoscopy-America | $72.74 | 2021-2022 | |
| Med-El Corporation | $67.34 | 2024 | Adhear Professional Kit, Bci 602 Kit, Mi1250 Synchrony 2 Flexsoft |
| Intersect Ent, INC. | $47.46 | 2022 | |
| Atos Medical INC | $28.53 | 2025 | Provox Life Home Hme |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheyenne Roohani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.